INGENIA THERAPEUTICS
Ingenia Therapeutics provider of undisclosed products and services based in Cambridge, Massachusets.
INGENIA THERAPEUTICS
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(781) 491-9005
Total Funding:
4.71 M USD
Similar Organizations
858 Therapeutics
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.
Gage Cannabis
Gage Cannabis is a craft cannabis brand and operator.
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
Current Employees Featured
Founder
More informations about "Ingenia Therapeutics"
INGENIA Therapeutics
INGENIA Therapeutics is a research-driven biotechnology company. We are committed to the discovery and development of advanced therapeutics for patients afflicted by inflamed and โฆSee details»
Ingenia Therapeutics - Crunchbase Company Profile & Funding
Ingenia Therapeutics is a biotechnology company developing a therapeutic antibody candidate to treat multiple diseases, including cancer and inflammatory diseases. It specializes in โฆSee details»
INGENIA Therapeutics 2025 Company Profile: Valuation, Funding ...
INGENIA Therapeutics General Information Description. Developer of a therapeutic antibody candidate designed for capillary diseases. The company specializes in discovering and โฆSee details»
INGENIA Therapeutics
Sangyeul Han founded INGENIA Therapeutics in 2018. Previously, he worked at Cell Signaling Technology where he led its Antibody Technology and Molecular Biology groups. Before CST, โฆSee details»
INGENIA Therapeutics - LinkedIn
INGENIA Therapeutics | 971 followers on LinkedIn. INGENIA Therapeutics strives to develop antibodies to treat multiple diseases including cancer & inflammatory diseases | INGENIA Therapeutics, a ...See details»
Ingenia Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Nov 30, 2022: Venture Round โฆSee details»
Ingenia Therapeutics Inc. (Ingenia Therapeutics Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
About INGENIA Therapeutics INGENIA is a privately held biotechnology company specializing in a proprietary microvasculature protection technology aimed at offering a means to rehabilitate โฆSee details»
Ingenia Therapeutics - VentureRadar
INGENIA Therapeutics has developed a portfolio of novel biotherapeutic candidates to halt and reverse chronic disease progression by restoring dysfunctional vasculature to its healthy state. โฆSee details»
Ingenia Therapeutics Inc. Company Profile - Dun & Bradstreet
Ingenia Therapeutics Inc. Company Profile | Watertown, MA | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Ingenia Therapeutics - 2025 Company Profile - Tracxn
6 days ago Ingenia Therapeutics has filed a notice of an exempt offering of securities to raise $25,000,000.00 in New Equity Investment.intelligence360 โข Jul 04, 2024 โข Ingenia โฆSee details»
Nona Biosciences and INGENIA Therapeutics Enter into โฆ
Oct 13, 2023 About INGENIA Therapeutics INGENIA is a privately held biotechnology company specializing in a proprietary microvasculature protection technology aimed at offering a means โฆSee details»
INGENIA THERAPEUTICS INC. - CAGE.report
INGENIA THERAPEUTICS INC. DUNS 117300305 / 11-730-0305. NCAGE Code: 8FEB3. INGENIA THERAPEUTICS INC. CAGE Code: 8FEB3. INGENIA THERAPEUTICS INC. D-U-N โฆSee details»
Ingenia Therapeutics - Contacts, Employees, Board Members
Organization. Ingenia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 3. โฆSee details»
Technology - INGENIA Therapeutics
By modifying endothelial cell signaling, INGENIA technology provides breakthrough vascular therapeutics. Based on our deep understanding of endothelial biology, we found a unique way โฆSee details»
Ingenia Therapeutics - Products, Competitors, Financials, โฆ
Nona Biosciences and INGENIA Therapeutics Enter into Collaboration Agreement. Oct 14, 2023. ๋ซ๊ธฐ CAMBRIDGE, Mass., Oct. 13, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer โฆSee details»
Ingenia Therapeutics - workinbiotech.com
INGENIA Therapeutics is developing durable best-in-class therapeutic antibodies, restoring dysfunctional microvessels into their healthy state in multiple ophthalmic and systemic โฆSee details»
IGT-302 - Drug Targets, Indications, Patents - Synapse - Patsnap
Jan 23, 2025 IGT-302, Initially developed by Ingenia Therapeutics Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Eye Diseases, Active Indication: Glaucoma, โฆSee details»
Nona Biosciences and INGENIA Therapeutics Enter into โฆ
CAMBRIDGE, Mass., Oct. 13, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and INGENIA โฆSee details»
Federal government announces support for cutting-edge, AI- and โฆ
6 days ago Since March 2020, over $2.3 billion has been invested to rebuild Canadaโs vaccines, therapeutics and biomanufacturing capacity across our country. Today, the Honourable Anita โฆSee details»
Eterna Therapeutics Changes Name to Ernexa Therapeutics to
3 days ago --Eterna Therapeutics, a leader in cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the companyโ s new name: Ernexa โฆSee details»